Related Experiment Video
Updated: Jul 18, 2026

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
Published on: February 26, 2017
Lactic acidosis in children with acute exacerbation of severe asthma
Insights
Intensive use of nebulized beta2-agonists for severe pediatric asthma may cause lactic acidosis. Symptoms improved after reducing or stopping the medication, suggesting a direct link.
Area of Science:
- Pediatric Intensive Care Medicine
- Respiratory Medicine
- Clinical Biochemistry
Background:
- Acute severe asthma in children requires intensive treatment.
- Nebulized beta2-agonists are a cornerstone therapy for acute severe asthma.
- Potential adverse effects of high-dose beta2-agonist therapy require ongoing investigation.
Observation:
- Four pediatric patients with acute severe asthma developed lactic acidosis during intensive nebulized beta2-agonist treatment.
- Peak lactic acidosis concentrations ranged from 5.2 to 13 mmol/l.
- Lactic acidosis resolved within 24 hours after discontinuing or decreasing beta2-agonist dosage.
Findings:
- Intensive nebulized beta2-agonist therapy is a potential cause of lactic acidosis in pediatric patients with severe asthma.
- The severity of lactic acidosis correlated with beta2-agonist dosage.
- Discontinuation or dose reduction of beta2-agonists led to rapid improvement of lactic acidosis.
Implications:
- Clinicians should consider lactic acidosis as a potential complication of intensive beta2-agonist therapy in pediatric severe asthma.
- Monitoring lactate levels may be warranted in pediatric patients receiving high-dose beta2-agonists.
- Further research is needed to elucidate the mechanism and confirm the association between beta2-agonists and lactic acidosis in this population.
Abstract:
This is a retrospective case series reporting lactic acidosis in four pediatric patients with acute severe asthma treated with nebulized beta2-agonists in a pediatric intensive care unit of a tertiary care teaching facility. During treatment with beta2-agonists, these patients developed lactic acidosis with a peak concentration of 5.2 to 13 mmol/l. Lactic acidosis improved within 24 h after discontinuation or decrease in the dosage of beta2-agonists. We conclude that the intensive use of beta2-agonists for acute severe asthma in children may be the primary and significant cause of lactic acidosis.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-III
Diabetic Ketoacidosis l: Introduction
Asthma III: Clinical Manifestations
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Asthma-III: Symptoms and Complications
Classification of Asthma
Diabetic Ketoacidosis ll: Pathophysiology

